UK cost-effectiveness analysis of endoscopic sleeve gastroplasty versus lifestyle modification alone for adults with class II obesity.
Menon, Vinod O'Neill, Frank Elliot, Laura Combe, Emily Drinkwater, Will Abbott, Sally Hayee, BuHussain Menon, Vinod
Menon, Vinod
O'Neill, Frank
Elliot, Laura
Combe, Emily
Drinkwater, Will
Abbott, Sally
Hayee, BuHussain
Menon, Vinod
Abstract
Endoscopic sleeve gastroplasty (ESG) is a minimally invasive procedure that has been demonstrated in the MERIT randomised, controlled trial to result in substantial and durable additional weight loss in adults with obesity compared with lifestyle modification (LM) alone. We sought to conduct the first cost-effectiveness analysis of ESG versus LM alone in adults with class II obesity (BMI 35.0-39.9 kg/m2) from a national healthcare system perspective in England based on results from this study.
MIDER Authors
Affiliations
Kelly J, Menon V, O'Neill F, Elliot L, Combe E, Drinkwater W, Abbott S, Hayee B
Citations
Altmetric:
Date
2023-09-06
Type
Article
Subject
Collections
Citation
Kelly J, Menon V, O'Neill F, Elliot L, Combe E, Drinkwater W, Abbott S, Hayee B